Skip to content
Pharma Observatory a Scientist.com platform
  • Supplier site
  • Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

XCell Science Laboratory

XCell Science Laboratory is listed as a small business research supplier in the Scientist.com network, with 2 sites in 1 country.

View XCell Science Laboratory on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 2
Countries 1

Services

What this research supplier says it provides, as listed in the Scientist.com network.

Type of company: Small business

Cell Culture and Characterization

  • Isogenic Knockout iPSC Lines Mimic loss of function of genes associated with various diseases and disorders.

In Vitro Pharmacology

  • In Vitro Neural Models Use cultured neurons, neuronal progenitor cells and stem cell differentiation to create cellular models of neurological disease.

Source: Scientist.com supplier network

Where it operates

Sites by country, with the cities in each.

  • United States Novato 2 sites

Source: Scientist.com supplier network (site locations)

About this supplier

In the supplier's own words, as listed in the Scientist.com network.

XCell Science Laboratory is a biotechnology company dedicated to providing reagents and services to the stem cell community. Our mission is to make pluripotent stem cell (PSC) technology available to all researchers. Our core business focuses on the generation of high quality neural cells from human PSC and on the development of scalable processes to produce large quantities of neural derivatives for use in drug discovery, toxicology, and cell replacement therapy. Building on the expertise and proprietary technology of our founder, we have developed a portfolio of human PSC-derived neural...

Show the full description

XCell Science Laboratory is a biotechnology company dedicated to providing reagents and services to the stem cell community. Our mission is to make pluripotent stem cell (PSC) technology available to all researchers. Our core business focuses on the generation of high quality neural cells from human PSC and on the development of scalable processes to produce large quantities of neural derivatives for use in drug discovery, toxicology, and cell replacement therapy.

Building on the expertise and proprietary technology of our founder, we have developed a portfolio of human PSC-derived neural derivatives along with associated media and reagents. We have also developed expertise in engineering human iPSC using cutting edge homologous recombination techniques including the use of ZFN and TALEN technologies.

At the present time we offer ready-to-use neurons, dopaminergic neurons and astrocytes derived from XCell’s integration-free iPSC lines, engineered reporter sub-clones, and a panel of genetically modified iPSC lines for the study of central nervous system (CNS) disorders. We also offer comprehensive custom services including generation of iPSC, targeted genetic modifications of iPSC and directed differentiation of iPSC to neural stem cells, neurons, dopaminergic neurons and astrocytes at very competitive prices. We are proud to note that our products have already helped users in the academic, pharmaceutical and biotechnology arenas.

Professional associations
BayBio
Website
xcell2.com

Source: Scientist.com supplier network, written by the supplier

Get the XCell Science Laboratory report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Sources: Scientist.com supplier network.

Work with XCell Science Laboratory on Scientist.com

For prices, more details, or to contact XCell Science Laboratory, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.